- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00988403
Investigation of Dietary Absorptive Capacity of Fructans in Healthy Subjects - A Dose Response Study
Investigation of Dietary Absorptive Capacity of Fructans in Healthy Subjects - A Randomized, Double-Blind Dose Response Study
Fructan is a carbohydrate polymer that is composed of fructose and a terminal glucose moiety . Fructans are naturally found in artichokes (6.1 grams/serving), leeks (5.9 grams/serving), onion bulbs (1.01 grams/serving), flour (4.0 grams/serving), garlic (.52 grams/serving), watermelon (.92 grams/serving), nectarines (.27 grams/serving) and white peaches (.50 grams/serving). Because fructans are present in many common foods, people typically ingest high levels of fructan. The most common structural forms of fructan are inulin, levanare and geraminan . The human body absorbs only 5% of fructan, however it is estimated that the daily intake in the USA may vary between 1-20 grams, and possibly higher due to the recently discovered benefits of inulins . Dietary trends indicate that high levels of fructans are common in the European and American diet, as more wheat based products such as breakfast cereal, pasta, and bread are consumed.
Fructans may not be well tolerated by some subjects and its malabsorption may result in gastrointestinal (GI) symptoms such as heartburn, belching, abdominal pain, diarrhea, gas, and bloating; and this is especially true when higher doses are ingested. Unlike glucose, fructans are not efficiently digested or absorbed by the small intestine. The mechanism for malabsorption is related to the inability to hydrolyze glycosidic linkages in the complex polysaccharide, resulting in the delivery of malabsorbed fructans to the large bowel1. In the colon, the malabsorbed fructans are rapidly fermented, and byproducts of this fermentation include H2, CH4, and other gases that may contribute to bowel symptoms. Furthermore, the small molecular nature of fructans results in an osmotic effect which draws more water into the small intestine and causes bloating and diarrhea.
Ingestion of high doses of fructans can cause symptoms in healthy adults, but may cause more bothersome symptoms in subjects with Irritable Bowel Syndrome (IBS). Earlier studies have identified that IBS affects between 10 and 15% of the population in the United States. Ingestion of 10-20 grams of fructan daily may cause symptoms of IBS, and restricting fructan intake in a diet may reduce symptoms in a variety of gastrointestinal disorders. One study recently published found that dietary restriction of fructan and fructose was responsible for symptomatic improvement in patients with IBS.
Hypothesis:
The investigators hypothesize that healthy individuals will absorb fructan 7.5 gram and 10 gram doses, and will experience malabsorption at the 12.5 gram fructan dose.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Iowa
-
Iowa City, Iowa, United States, 52242
- University of Iowa Hospitals and Clinics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy volunteers between the ages of 18-70 years, with no previous history of gastrointestinal problems or any other ailments, no history of gastrointestinal surgery except appendectomy, cholecystectomy, caesarean section, hysterectomy and currently not using any medication except contraceptive pill, multivitamin, or aspirin.
- They will be asked to fill out a Review of Systems health history (Appendix 2) and the Mayo Clinic Bowel Disease Questionnaire (Appendix 3) and will undergo a routine physical examination. Only patients who are asymptomatic and deemed healthy from the aforementioned screening procedure will be eligible.
Exclusion Criteria:
- Currently taking medication for any ailment including OTC medication (excluding aspirin, multivitamins, and oral contraceptives)
- History of gastrointestinal problems including bloating, gas, food intolerances or reflux symptoms
- Any major abdominal surgery (except appendectomy, cholecystectomy, caesarean section, hysterectomy) or coexisting medical problem
- Known food allergies
- Prisoners
- Cognitive Impairment or any other inability to provide informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Fructan - 7.5
Subjects will consume 7.5 grams of fructan
|
Subjects will consume 7.5 grams of fructan
Other Names:
|
Experimental: Fructan - 10 grams
Subjects will consume 10 grams of fructan
|
Subjects will consume 10 grams of fructan
Other Names:
|
Experimental: Fructan - 12.5 grams
Subjects will consume 12.5 grams of fructan
|
Subjects will consume 12.5 grams of fructan
Other Names:
|
Experimental: 5 grams Fructan
Experimental - 5 grams Fructan Subjects will consume 5 grams of Fructan. |
Subjects will consume 5 grams fructan.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hydrogen and Methane Concentration levels
Time Frame: 3 visits over a 1 month period
|
Measure breath sample concentration for hydrogen and methane levels in parts per million
|
3 visits over a 1 month period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Production of GI Symptoms
Time Frame: 3 visits over a 1 month period
|
Production of bothersome GI symptoms such as gas, bloating, cramping or abdominal pain during breath test.
Symptoms were mesured using a validated symptom questionnaire.
|
3 visits over a 1 month period
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Satish Rao, MD, PhD, Augusta University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Fructan
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Hangzhou Sciwind Biosciences Co., Ltd.RecruitingHealthy VolunteersChina
Clinical Trials on Fructan - 7.5
-
University of ManitobaRecruitingInflammatory Bowel Diseases | Ulcerative ColitisCanada
-
Baylor College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedIrritable Bowel Syndrome (IBS)United States
-
Beneo-InstituteCompletedInfectious Disease | Diet Modification | Children, Only
-
Sahlgrenska University Hospital, SwedenBeneo-Institute; Atmo Biosciences Pty LtdRecruitingIrritable Bowel Syndrome With DiarrheaSweden
-
BIO-CAT, Inc.Nutrasource Pharmaceutical and Nutraceutical Services, Inc.CompletedGastrointestinal Health | Digestive HealthCanada
-
GlaxoSmithKlineCompletedAtherosclerosisUnited Kingdom
-
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.Not yet recruitingObesity | Overweight
-
Laval UniversityCompletedAcute Coronary Syndrome | Stable Angina | Unstable AnginaCanada
-
University of NottinghamCompleted
-
Johann Wolfgang Goethe University HospitalPfrimmer Nutricia GmbH, Erlangen , GermanyCompletedEnd-Stage Renal DiseaseGermany